Metheptazine

Metheptazine is an opioid analgesic from the phenazepine family. It was developed by American Home Products in the 1950s.[1]

Metheptazine

Clinical data
Other names	Metheptazine
ATC code	none
Identifiers
IUPAC name methyl 1,2-dimethyl-4-phenylazepane-4-carboxylate
CAS Number	469-78-3 N
PubChem CID	3047717
ChemSpider	2310051 Y
UNII	93X4R66P5A
ChEMBL	ChEMBL2104520 N
Chemical and physical data
Formula	C16H23NO2
Molar mass	261.36 g/mol g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C(OC)C2(c1ccccc1)CC(N(C)CCC2)C
InChI InChI=1S/C16H23NO2/c1-13-12-16(15(18)19-3,10-7-11-17(13)2)14-8-5-4-6-9-14/h4-6,8-9,13H,7,10-12H2,1-3H3 Y Key:RAAFYFKWMRWOIT-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Metheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.

Metheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.[2] The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.